Laboratório Químico Farmacêutico Bergamo Ltda.
🇧🇷Brazil
- Country
- 🇧🇷Brazil
- Ownership
- Subsidiary
- Established
- 2011-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure
Phase 3
- Conditions
- Chronic Renal Failure
- First Posted Date
- 2011-05-02
- Last Posted Date
- 2011-05-02
- Lead Sponsor
- Laboratório Químico Farmacêutico Bergamo Ltda.
- Target Recruit Count
- 132
- Registration Number
- NCT01346215
- Locations
- 🇧🇷
Instituto de Nefrologia de Campinas, Campinas, São Paulo, Brazil
News
No news found